Sumatriptan pregnancy category

The Prescribing medicines in pregnancy database classifies sumatriptan as: Drug name, Category, Classification Level 1, Classification Level 2

Parenteral diclofenac and subcutaneous sumatriptan Botulinum toxin type A was classified as a category C drug according to the old FDA pregnancy risk

Pregnancy Category C. There are no adequate and well-controlled trials in pregnant women. Sumatriptan is excreted in human milk following subcutaneous

pregnancy. Sumatriptan falls into category C. In animal studies, pregnant animals were given this medication and had some babies born with

Ensure that a neurological examination has been performed to identify appropriate migraine category Do not use sumatriptan injection if pregnancy is suspected

Triptans are in pregnancy category C. While sumatriptan is probably safe in breastfed neonates, the exact risk of zolmitriptan and rizatriptan is unknown.

Advice and warnings for the use of Sumatriptan during pregnancy. FDA Pregnancy Category C - Risk cannot be ruled out.

Pregnancy. Teratogenic Effects: Pregnancy Category C. In reproductive toxicity studies in rats and rabbits, oral treatment with sumatriptan was associated with embryolethality, fetal abnormalities, and pup mortality.

Pregnancy. Teratogenic Effects: Pregnancy Category C. In reproductive toxicity studies in rats and rabbits, oral treatment with sumatriptan was associated with embryolethality, fetal abnormalities, and pup mortality. When administered by the intravenous route to rabbits, sumatriptan has been shown to be embryolethal.